January 14, 2013 at 08:35 AM EST
EmergingGrowth.com Reports on Fiscal Cliff Deal and Amyris, Inc.
EmergingGrowth.com Reports on Fiscal Cliff Deal and Amyris, Inc.

EmergingGrowth.com, a leading digital financial media company, Reports on Amyris, Inc. (NASDAQ: AMRS).  Discussion also includes Codexis Inc., (NASDAQ: CDXS) and Futurefuel (NYSE: FF).

 

Feature your company on EmergingGrowth.com.  Visit EmergingGrowth.com to find out how. 

 

Amyris Inc., (NASDAQ:AMRS) is an integrated renewable products company. Its focus is on providing sustainable option s to a wide range of petroleum-sourced product used in specialty chemical and transportation fuel markets worldwide. Its synthetic biology platform converts plant sugars into an assortment of hydrocarbon based molecules. These supple building blocks can be used in an assortment of products. Amyris is currently utilizing Brazilian sugarcane as its chief feedstock.

 

Shares of the company have rallied over 25 percent in the past week. Prices have moved between a 52 week high of $11.75 and a 52 week low of $1.57 and are now trading 140% above that low price at $3.88 per share. Over the last five market days, the 200-day moving average (MA) has gone down 1.2 percent while the 50 day MA has risen1.0 percent. The Alternative Energy Industry got huge support this week as a last-minute deal by congress to get around the "fiscal cliff," unexpectedly included the extension of tax credits for renewable energy and alternative fuels.

 

Reports indicate recent heavy insider trading, especially by company execs. Fernando Reinach, a director of Amyris, bought 83,892 shares on December 24, 2012. John Doerr purchased an additional 1,677,852 shares on the same date, upping his ownership of the company to a total of 6,979,757 shares which translates to a tidy 9.4 percent of the company. Sheikh Abdullah Bin Khalifa Al Thani, also a director, bought 3,355,704 shares to add to what he already. His shares translate to 8.0% ownership of Amyris. All these transactions were carried out in pursuant to private placements.

 

Amyris has a market cap of $ 230.35 million. Shares are trading at $3.88. This is a terrific small-cap short play right now as the company rides the rally connected with the unexpected largesse of our nation’s law makers. The company’s closest competitors in the industrial synthetic biology industry are Codexis Inc., (NASDAQ: CDXS), currently trading at $2.66 with a market cap of $99.89 million and FutureFuel (NYSE: FF), currently trading at $12.22 and market cap of $505 million. All three companies may make for a good, largely unexpected short play right now.

 

About EmergingGrowth.com

 

By offering 100% original and unmatched content by the best financial reporters, writers and bloggers in the business, EmergingGrowth.com is emerging as a leading digital financial media portal. Its services provide users, subscribers and advertisers with a variety of content and tools through a range of online, social media, mobile and other mobile outlets.

 

Since its inception, EmergingGrowth.com has distinguished itself from other financial media companies with its sly approach to reading between the lines in order to locate that needle in the haystack.  Sign up today to see what EmergingGrowth.com has to offer.

NEW:  Feature your company on EmergingGrowth.com.  Find out how by filling out our form at http://emerginggrowth.com/recommend-a-company-to-feature-on-emerging-growth

 

Contact:

EmergingGrowth.com

info@EmergingGrowth.com

305-323-5687

 

Join our Linked in Group

 

Like us on Facebook


Disclosure

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. In addition, Please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website. Always remember that investing in securities such as the ones listed within are for high-risk tolerant individuals only and not the general public. Whether you are an experienced investor or not, you should always consult with a stockbroker, financial advisor, or similar before purchasing or selling any securities viewed on any emails sent from EmergingGrowth.com or its website.
 

 

SOURCE EmergingGrowth.com

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here